Association between clinicopathologic characteristics and BRAF V600E expression in Chinese patients with Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Association between clinicopathologic characteristics and BRAF V600E expression in Chinese patients with Langerhans cell histiocytosis

Published:2019-08-23 Issue:10 Volume:10 Page:1984-1992
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Huang Hui¹^ORCID,Lu Tao²,Sun Yuxin¹,Li Shan¹,Li Ji²,Xu Kai³,Feng Rui e²^ORCID,Xu Zuo jun¹

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical College Beijing China

2. Pathological Department, Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical College Beijing China

3. Radiological Department, Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13179

Reference26 articles.

1. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

2. Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan

3. Langerhans cell histiocytosis in Chinese adults: Absence of BRAF mutations and increased FOXP3(+) regulatory T cells;Tong C;Int J Clin Exp Pathol,2014

4. Frequent BRAFV600E mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis

5. BRAFV600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Кладрибин в лечении многоочагового мультисистемного гистиоцитоза из клеток Лангерганса у пациента с неблагоприятным прогнозом. Клиническое наблюдение;Clinical Oncohematology;2024-07-01

2. Multi-System Langerhans Cell Histiocytosis as a Mimic of IgG4-Related Disease: A Case Report and Literature Review;Frontiers in Endocrinology;2022-07-22

3. The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial;BMC Cancer;2020-05-18

4. Pediatric Langerhans Cell Histiocytosis with BRAF Mutation Affecting Sacral Vertebra: A Case Report and Disease Review;Pediatric Neurosurgery;2020